Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.000
-0.110 (-2.68%)
At close: Feb 27, 2026, 4:00 PM EST
4.010
+0.010 (0.25%)
After-hours: Feb 27, 2026, 7:57 PM EST
Aquestive Therapeutics Employees
Aquestive Therapeutics had 142 employees as of December 31, 2024. The number of employees increased by 7 or 5.19% compared to the previous year.
Employees
142
Change (1Y)
7
Growth (1Y)
5.19%
Revenue / Employee
$305,613
Profits / Employee
-$485,768
Market Cap
488.01M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 420 |
| Evolus | 329 |
| Esperion Therapeutics | 304 |
| Ironwood Pharmaceuticals | 253 |
| Akebia Therapeutics | 181 |
AQST News
- 11 hours ago - AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - PRNewsWire
- 2 days ago - INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - GlobeNewsWire
- 3 days ago - Aquestive Therapeutics to Participate in Upcoming March Investor Conferences - GlobeNewsWire
- 4 days ago - Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET - GlobeNewsWire
- 9 days ago - AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - GlobeNewsWire
- 11 days ago - INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - Newsfile Corp
- 11 days ago - Aquestive Therapeutics: Biology Validated, Packaging Pending - A Forensic Analysis Of The Anaphylm CRL - Seeking Alpha
- 13 days ago - AQST SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - GlobeNewsWire